IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 59 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,265,841 | +21.7% | 24,390 | +40.6% | 0.00% | – |
| Q2 2023 | $1,040,066 | +45.5% | 17,346 | +20.0% | 0.00% | – |
| Q1 2023 | $714,803 | +86542.8% | 14,458 | 0.0% | 0.00% | – |
| Q4 2022 | $825 | -99.9% | 14,458 | -12.2% | 0.00% | – |
| Q3 2022 | $772,000 | +25.7% | 16,464 | 0.0% | 0.00% | – |
| Q2 2022 | $614,000 | +117.0% | 16,464 | +73.8% | 0.00% | – |
| Q1 2022 | $283,000 | +38.0% | 9,475 | +58.0% | 0.00% | – |
| Q4 2021 | $205,000 | -7.7% | 5,997 | 0.0% | 0.00% | – |
| Q3 2021 | $222,000 | -5.1% | 5,997 | 0.0% | 0.00% | – |
| Q2 2021 | $234,000 | – | 5,997 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
| Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
| RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
| Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
| Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
| GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
| COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
| Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |